Related Experiment Video
Updated: May 12, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and
Ruoxing Wang1, Jundi Wang, Amber M Paul
1Department of Biological Sciences, University of Southern Mississippi, Hattiesburg, Mississippi 39406, USA.
Abstract:
Embryonic stem cells (ESCs) are considered to be a promising cell source for regenerative medicine because of their unlimited capacity for self-renewal and differentiation. However, little is known about the innate immunity in ESCs and ESC-derived cells. We investigated the responses of mouse (m)ESCs to three types of live viruses as follows: La Crosse virus, West Nile virus, and Sendai virus. Our results demonstrated mESCs were susceptible to viral infection, but they were unable to express type I interferons (IFNα and IFNβ, IFNα/β), which differ from fibroblasts (10T1/2 cells) that robustly express IFNα/β upon viral infections. The failure of mESCs to express IFNα/β was further demonstrated by treatment with polyIC, a synthetic viral dsRNA analog that strongly induced IFNα/β in 10T1/2 cells. Although polyIC transiently inhibited the transcription of pluripotency markers, the stem cell morphology was not significantly affected. However, polyIC can induce dsRNA-activated protein kinase in mESCs, and this activation resulted in a strong inhibition of cell proliferation. We conclude that the cytosolic receptor dsRNA-activated protein kinase is functional, but the mechanisms that mediate type I IFN expression are deficient in mESCs. This conclusion is further supported by the findings that the major viral RNA receptors are either expressed at very low levels (TLR3 and MDA5) or may not be active (retinoic acid-inducible gene I) in mESCs.
Insights
Embryonic stem cells (ESCs) are susceptible to viral infections but cannot produce type I interferons (IFNα/β). This deficiency in innate immunity hinders their use in regenerative medicine.
Area of Science:
- Immunology
- Stem Cell Biology
- Virology
Background:
- Embryonic stem cells (ESCs) hold great promise for regenerative medicine due to their self-renewal and differentiation potential.
- The innate immune responses of ESCs and their derivatives remain largely uncharacterized.
- Understanding ESC immunity is crucial for their safe and effective therapeutic applications.
Purpose of the Study:
- To investigate the innate immune responses of mouse embryonic stem cells (mESCs) to viral infections.
- To determine the capacity of mESCs to express type I interferons (IFNα/β) upon viral challenge.
- To elucidate the mechanisms underlying potential immune deficiencies in mESCs.
Main Methods:
- Exposure of mESCs to live viruses (La Crosse, West Nile, Sendai) and polyinosinic:polycytidylic acid (polyIC).
- Quantification of type I interferon (IFNα/β) expression.
- Assessment of dsRNA-activated protein kinase (PKR) activation and cell proliferation.
- Analysis of viral RNA receptor expression (TLR3, MDA5, RIG-I).
Main Results:
- mESCs are susceptible to viral infection but fail to express type I interferons (IFNα/β), unlike fibroblasts.
- PolyIC treatment, a viral dsRNA analog, induces dsRNA-activated protein kinase (PKR) in mESCs, inhibiting proliferation.
- Key viral RNA receptors, including TLR3 and MDA5, are expressed at low levels in mESCs, and RIG-I may be inactive.
Conclusions:
- mESCs possess functional cytosolic dsRNA-activated protein kinase (PKR) but exhibit deficient mechanisms for type I interferon (IFNα/β) expression.
- Low expression or activity of viral RNA sensors contributes to the impaired innate immune response in mESCs.
- These innate immune deficiencies in ESCs require consideration for their application in regenerative medicine.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Experimental RNAi
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...